Related Experiment Video
Updated: May 6, 2026

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
Published on: November 13, 2015
Sirt4 Deficiency Promotes Cardiomyocyte Proliferation and Cardiac Repair
Weijing Liu1,2, Jie Feng1,3, Yuan Zhang4
1State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Insights
Sirt4 protein inhibits heart regeneration by damaging DNA and stopping cardiomyocyte proliferation. Sirt4 deficiency promotes heart repair and improves function after injury, suggesting Sirt4 inhibition as a potential therapy.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Regenerative Medicine
Background:
- Mammalian hearts have limited regenerative capacity post-birth.
- Cardiomyocyte cell cycle exit limits cardiac repair.
- The role of sirtuins in cardiomyocyte proliferation is largely unknown.
Purpose of the Study:
- Investigate the role of Sirt4 in cardiomyocyte proliferation.
- Determine Sirt4's impact on cardiac regeneration and repair.
- Evaluate Sirt4 as a therapeutic target for heart disease.
Main Methods:
- Assessed Sirt4 expression during heart development.
- Utilized in vitro and in vivo models with Sirt4 overexpression.
- Examined Sirt4-knockout mice and adult mice subjected to ischemia-reperfusion injury.
Main Results:
- Sirt4 overexpression inhibited cardiomyocyte proliferation and neonatal heart regeneration.
- Sirt4 deficiency enhanced cardiomyocyte proliferation and extended the regeneration window.
- Sirt4 knockout improved cardiac function and reduced fibrosis post-injury.
Conclusions:
- Sirt4 is a key regulator of cardiomyocyte proliferation and cardiac repair.
- Targeting Sirt4 inhibition offers a potential therapeutic strategy for ischemic heart diseases.
- Modulating Sirt4 could enhance cardiac regenerative capacity.
Abstract:
The mammalian heart exhibits transient but remarkable regenerative capacity during the early postnatal period, after which most cardiomyocytes exit the cell cycle. While the sirtuin family is well-established as regulators of cell cycle progression, its specific role in cardiomyocyte proliferation and cardiac regeneration remains unclear. In this study, we found that Sirt4 expression increased during postnatal heart development. Adenovirus-mediated Sirt4 overexpression in vitro inhibited cardiomyocyte proliferation by inducing oxidative DNA damage. Moreover, cardiomyocyte-specific Sirt4 overexpression in vivo suppressed cardiomyocyte proliferation and impaired neonatal heart regeneration. Using Sirt4-knockout mice, we found that Sirt4 deficiency promoted cardiomyocyte proliferation and extended the heart regeneration window. Furthermore, Sirt4 deficiency improved cardiac function and reduced myocardial fibrosis after ischaemia-reperfusion injury in adult mice. These findings establish Sirt4 as a critical regulator of cardiomyocyte proliferation and cardiac repair, suggesting that targeted Sirt4 inhibition may represent a promising therapeutic strategy for ischaemic heart diseases.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Renewal of Skin Epidermal Stem Cells
Tissue Renewal without Stem Cells
However, failure of such a system...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
The Effect of Aging on Tissues
Cardiomyopathy IV: Restrictive Cardiomyopathy

